Abstract

The recent outbreaks of Ebola virus (EBOV) infections have underlined the impact of the virus as a major threat for human health. Due to the high biosafety classification of EBOV (level 4), basic research is very limited. Therefore, the development of new avenues of thinking to advance quantitative comprehension of the virus and its interaction with the host cells is urgently needed to tackle this lethal disease. Mathematical modeling of the EBOV dynamics can be instrumental to interpret Ebola infection kinetics on quantitative grounds. To the best of our knowledge, a mathematical modeling approach to unravel the interaction between EBOV and the host cells is still missing. In this paper, a mathematical model based on differential equations is used to represent the basic interactions between EBOV and wild-type Vero cells in vitro. Parameter sets that represent infectivity of pathogens are estimated for EBOV infection and compared with influenza virus infection kinetics. The average infecting time of wild-type Vero cells by EBOV is slower than in influenza infection. Simulation results suggest that the slow infecting time of EBOV could be compensated by its efficient replication. This study reveals several identifiability problems and what kind of experiments are necessary to advance the quantification of EBOV infection. A first mathematical approach of EBOV dynamics and the estimation of standard parameters in viral infections kinetics is the key contribution of this work, paving the way for future modeling works on EBOV infection.

Highlights

  • Ebola was characterized for the first time in 1976 close to the Ebola River located in the Democratic Republic of the Congo (WHO, 1978)

  • Significant progress has been made to the identification and characterization of Ebola virus (EBOV), human data is very limited due to the long asymptomatic periods of the virus and its high mortality

  • The work presented here focused on the interaction between EBOV and the host cells, i.e., epithelial cells of green monkey

Read more

Summary

Introduction

Ebola was characterized for the first time in 1976 close to the Ebola River located in the Democratic Republic of the Congo (WHO, 1978). Outbreaks of EBOV among humans have appeared sporadically causing lethal diseases in several African countries, mainly in Gabon, South Sudan, Ivory Coast, Uganda, and South Africa (CDC, 2014). Among the most severe symptoms of the EBOV disease are fever, muscle pain, diarrhea, vomiting, abdominal pain and the unexplained hemorrhagic fever (Calain et al, 1999). The pathogenesis of the disease is still poorly understood (Peters and Peters, 1999; Feldmann et al, 2003). Ebola virus belongs to the family of Filoviridae, from Latin filum which means thread (Carter and Saunders, 2013). Ebola virus is classified in Tai Forest, Sudan, Zaire, Reston, and Bundibugyo. The human Ebola epidemics have been mainly related to infection by the Zaire and Sudan strains

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call